Fidelity Investments
SGYP

Fidelity Investments’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Fidelity Investments’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,595,200
Closed -$8.79M – 2749
2016
Q3 		$8.79M Buy
+1,595,200
New +$7.47M ﹤0.01% 2034
2015
Q1 		– Sell
-1,688,356
Closed -$5.15M – 2824
2014
Q4 		$5.15M Sell
1,688,356
-782,600
-32% -$2.31M ﹤0.01% 2214
2014
Q3 		$6.88M Hold
2,470,956
– – ﹤0.01% 2137
2014
Q2 		$10.1M Sell
2,470,956
-182,700
-7% -$776K ﹤0.01% 2059
2014
Q1 		$14.1M Sell
2,653,656
-37,151
-1% -$208K ﹤0.01% 1908
2013
Q4 		$14.9M Sell
2,690,807
-811,200
-23% -$3.5M ﹤0.01% 1826
2013
Q3 		$15.8M Sell
3,502,007
-121,072
-3% -$543K ﹤0.01% 1781
2013
Q2 		$15.4M Buy
+3,623,079
New +$18.2M ﹤0.01% 1761

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments's SGYP Position: Q4 2016 in Review

Fidelity Investments sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 1,595,200 shares — an estimated $8.79M sold.

Fidelity Investments first reported a position in SGYP in Q2 2013 and held it in 8 quarters. The position peaked at $15.8M in Q3 2013. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • Fidelity Investments reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
  • Fidelity Investments sold 1,595,200 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $8.79M.
  • Fidelity Investments first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 8 quarters.
  • Fidelity Investments's Synergy Pharmaceuticals, Inc Common Stock position peaked at $15.8M in Q3 2013.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Fidelity Investments's 13F filing for Q4 2016, filed 10 Feb 2017.